Author: healthadmin

Sanofi is significantly increasing its artificial intelligence capabilities. The French pharmaceutical company will invest $294 million to expand its global AI center of excellence in Toronto, beginning to scale the digital infrastructure it built at its Canadian site four years ago. The expansion is supported by a conditional grant of up to $5 million from the Invest Ontario Fund and is expected to create 50 highly skilled jobs in AI, machine learning and data science by 2028, according to a May 4 release. This builds on a foundation of more than 150 roles already established in the field, across specialist…

Read More

Although the United States requires warning labels on alcoholic beverages, the number of alcohol-related deaths has steadily increased over the past two decades. But new labels warning of the risk of certain diseases, including cancer and liver disease, could increase motivation to drink less, researchers say. Journal of Alcohol and Drug Research. The warning labels currently required on alcohol containers in the United States have remained unchanged since their introduction in 1988, despite new evidence linking alcohol to several illnesses. Labels list the risks of drinking alcohol during pregnancy and while driving or operating machinery, and generally warn that drinking…

Read More

Startup Assort Health has developed an outbound AI agent that can proactively reach out to patients, automate appointment rescheduling, close unresolved referrals, work on payment collection, and accelerate the uptake of flu vaccinations. The AI ​​agent, called Assort Activate, is already being used by more than 1,000 healthcare providers and can improve patient access without adding staff, executives said. Assort Health will introduce specialty-specific agenttic AI voice agents in November 2023 to support practices ranging from orthopedics to cardiology to immunology, triaging incoming patient calls by answering frequently asked questions and routing patients to the right person within the clinic.…

Read More

A new study led by researchers at VIB and KU Leuven shows that Parkinson’s disease can be divided into different subtypes, helping to explain why no single treatment is effective for all patients. Using machine learning analysis, the team identified two main groups and five subgroups of the disease, marking an important step toward more personalized treatment. The results of this research have recently nature communications. “We have discovered two major subgroups that can be divided into five smaller groups of parkinsonism,” says Professor Patrick Verstreken (VIB-KU Leuven Neuroscience Center). Parkinson’s disease affects millions of people worldwide and is traditionally…

Read More

Intestinal ischemia/reperfusion (I/R) injury is a common pathophysiological phenomenon widely present in various primary intestinal diseases and systemic critical diseases, which can cause multiorgan dysfunction and failure, and is associated with high morbidity and mortality. Therefore, it is of paramount importance to investigate the mechanisms underlying intestinal inflammation/inflammatory responses and identify potential therapeutic targets. Recently, the research team of Professor Tian Xiaofeng of Dalian Medical University published a research paper dated April 9, 2026. Chinese medical journal Title: “Growth arrest and DNA damage-induced β (Gad 45B) MST1/Hippo promotes apoptosis in intestinal ischemia/reperfusion via DNA demethylation. ” The study reports: Gad…

Read More

Robert Blum and Fady Malik, MD, have been involved with Cytokinetics since its founding nearly 30 years ago. As they sat in a conference room Monday afternoon discussing the overwhelmingly successful trial results for Myqorzo (aficamten), it was a feeling of excitement and humility in equal measure. By meeting both primary endpoints in the Phase 3 ACACIA-HCM study, Cytokinetics is on track to become the first company to win approval for the treatment of non-obstructive hypertrophic cardiomyopathy (nHCM). Myqorzo was approved by the FDA last December to treat obstructive diseases, offering the potential for a blockbuster hit. According to claims…

Read More

Differences in the physical shape and wiring of the brain can directly contribute to the development of attention and social deficits. Recent genetic studies have mapped how the size of certain brain folds and the organization of brain wiring alter the risk of developing autism and attention-deficit hyperactivity disorder. The results of this study were published in the journal Progress in Neuropsychopharmacology & Biological Psychiatry. Autism spectrum disorder and attention deficit hyperactivity disorder are developmental disorders that can persist throughout a person’s life. These influence how individuals process information, regulate their attention spans, and participate in social interactions. People dealing…

Read More

Eating eggs is associated with a lower risk of being diagnosed with Alzheimer’s disease in people over 65, according to researchers at Loma Linda University School of Health. Researchers found that eating one egg a day for at least five days a week reduced the risk of Alzheimer’s disease by up to 27%. Eating at least five eggs a week can reduce your risk of Alzheimer’s disease compared to not eating eggs at all. ” Joanne Sabate, MD, PhD, Professor, Loma Linda University School of Public Health, Principal Investigator of the Study Even reducing the frequency of egg…

Read More

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1) and subsequently undergo metabolic/bariatric surgery can achieve significantly greater weight loss than with drug therapy alone, according to new research presented today at the American Society of Metabolic and Bariatric Surgery Annual Meeting (#ASMBS2026). Researchers at New York University Grossman School of Medicine found that patients treated with GLP-1 drugs, either semaglutide or tirzepatide, lost about 8% of their total body weight in the months before surgery. Total weight loss increased to more than 25% in patients who later switched to gastric bypass surgery and to approximately 20% in…

Read More